Incyte (INCY) Jingpynshai
AI forecast: INCY
Ka AI jingpynshai kaba lah ban ïaid ka jingpynshai kaba lah ban ïaid, ka jingpynshai kaba lah ban ïaid, ka jingpynshai kaba lah ban ïaid. Ka jingpynshai ka lah ban ïaid ka jingpynshai kaba lah ban ïaid. Ki jingpynshai ki jingpynshai kaba lah ban ïaid, ki jingpynshai kaba lah ban ïaid.
Price over the last 6 months
Premium ka thohi AI ka price targets ha 1 din, 1 saptah bad 1 mahin bar ki stock bad ki lain.
Unlock Premium🔒 Riñtiew ki forecast
Ka jingpynshai kaba lah ban ïaid — ki jingpynshai kaba lah ban ïaid ki jingpynshai kaba lah ban ïaid — ka jingpynshai kaba lah ban ïaid ka Premium.
Unlock PremiumAbout This Company
InCyte Corporation is focused on the opening, development and commercialization of patented therapeutic drugs for cancer in the United States and at the international level.